Feb 19, 2026 01:00AM
Feb 12, 2026 11:01AM
Nov 13, 2025 01:00AM
Nov 6, 2025 11:30AM
Aug 14, 2025 01:00AM
Aug 7, 2025 11:30AM
May 23, 2025 06:47AM Cantor Fitzgerald Reiterates Overweight Rating on Zealand Pharma A/S (ZEAL)
May 8, 2025 01:00AM
May 1, 2025 11:05AM
Feb 20, 2025 04:08AM
Feb 20, 2025 01:00AM
Nov 7, 2024 01:00AM
Aug 15, 2024 01:00AM
Aug 12, 2024 11:00AM Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results
May 16, 2024 01:00AM
May 9, 2024 10:00AM
Feb 27, 2024 01:00AM
Feb 20, 2024 02:00AM
Nov 9, 2023 01:00AM
Aug 17, 2023 01:00AM
May 11, 2023 01:00AM Zealand Pharma Announces Financial Results for the First Quarter of 2023
Mar 2, 2023 04:30AM
Mar 2, 2023 04:30AM
Mar 2, 2023 01:00AM
Mar 2, 2023 01:00AM
Nov 10, 2022 09:00AM
Nov 10, 2022 09:00AM
Aug 11, 2022 09:00AM Zealand Pharma Announces Financial Results for the First Half of 2022
Aug 11, 2022 09:00AM
May 12, 2022 09:00AM
May 12, 2022 09:00AM
Mar 11, 2022 11:08AM
Mar 11, 2022 11:08AM
Mar 10, 2022 09:01AM
Mar 10, 2022 09:00AM Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.
Mar 10, 2022 09:00AM
Nov 11, 2021 09:00AM
Nov 11, 2021 09:00AM
Aug 12, 2021 09:00AM
Aug 12, 2021 09:00AM
May 12, 2021 09:01AM
May 12, 2021 09:00AM Zealand Pharma receives first FDA approval and prepares for launch of Zegalogue® (dasiglucagon) injection
May 12, 2021 09:00AM
Mar 11, 2021 09:00AM
Mar 11, 2021 09:00AM
Jan 22, 2021 04:06PM
Jan 22, 2021 04:05PM
Jan 22, 2021 04:05PM
Nov 12, 2020 09:00AM Zealand Pharma continues to advance clinical programs and commercial launch capabilities and presents financial results for the first nine months of 2020
Nov 12, 2020 08:59AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All